SSTR1 inhibitors belong to a distinctive chemical class designed to target and modulate the activity of the somatostatin receptor subtype 1 (SSTR1). Somatostatin receptors, including SSTR1, are G protein-coupled receptors (GPCRs) that play a crucial role in regulating various physiological processes, such as hormone secretion, neurotransmission, and cell proliferation. SSTR1, specifically, is one of five subtypes of somatostatin receptors identified in humans. It is primarily expressed in the central nervous system and certain peripheral tissues, where it participates in the modulation of neurotransmission and synaptic activity.
The inhibitors of SSTR1 are characterized by their ability to selectively bind to and inhibit the activity of the SSTR1 receptor. These compounds often possess a specific molecular structure that enables them to interact with the receptor's binding site, thereby preventing the natural binding of somatostatin. By interfering with the normal functioning of SSTR1, these inhibitors may influence downstream signaling pathways and cellular responses associated with the receptor.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
13C6-Lys octreotide tri(trifluoroacetate) | 83150-76-9 (unlabeled free base) | sc-477942 | 500 µg | $396.00 | ||
Octreotide binds to SSTR1, reducing the level of growth hormone (GH) and insulin-like growth factor (IGF-1) in the plasma. | ||||||